Taken together, these findings support the use of the Tr‐Apt13–functionalized DP‐SIS platform for PD‐L1+ exosome detection as a promising liquid biopsy approach for precise prediction of immunotherapy efficacy and improved patient stratification in lung cancer. The gene discussed is CD274; the disease is lung carcinoma.